Analyst Ratings for Kymera Therapeutics (KYMR)
KYMR Rating Summary
KYMR Price Target Summary
- Highest: $170.00 (Guggenheim)
- Lowest: $80.00 (Citi)
- Average: $127.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$127.71 (+7.3%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
121.50 (119.05) |
-2.02% | Details |
| 7/30/2026 | Deutsche Bank | David Hoang | New Coverage | Hold (N/A) |
120.00 (N/A) |
106.16 (119.05) |
12.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
